PhaseBio Pharmaceuticals (PHAS) null Earnings

13MayConfirmed
Aug 20
Nov 20
Mar 21
May 21
-1.03
-0.86
-0.69
-0.52

Details

Expected EPS
-0.73
Actual EPS
-0.87
Surprise EPS
-0.14
Surprise Percent
+19.18%

Description

PhaseBio Pharmaceuticals (PHAS) has reported earnings of -0.87 per share for .

0 Comments

Share your thoughts